- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 85
Volvo Cars attaches itself to Niron Magnetics
Niron has collected $21.3m in funding from investors including Volvo Cars Tech Fund to build a pilot production facility for its rare earth-free magnets.
Jul 30, 2021Genomatica to grow with $118m series C
Novo led the sustainable materials producer’s series C round, three years after a round backed by investors including Ginkgo Bioworks.
Jul 30, 2021Isar Aerospace increases series B payload
TU Munich spinout Isar Aerospace has added $75m to its series B round, bringing the round’s total to nearly $166m and its overall financing to more than $183m.
Jul 29, 2021Microvast ties up $3bn reverse takeover
Koch Industries and Oshkosh are backing a $540m private placement supporting the merger between advanced battery maker Microvast and a special purpose acquisition company.
Jul 28, 2021Accion takes series C action
Tracker Capital Management has led a $42m series C round for Accion Systems, acquiring a majority stake in the MIT-linked company in the process.
Jul 28, 2021Phononic picks up $50m
NC State spinout Phononic has added $50m to its coffers thanks to a consortium led by Goldman Sachs.
Jul 28, 2021Albotherm seeds a green future
Based on research at University of Bristol, Albotherm’s technology could revolutionise how greenhouses and buildings are cooled.
Jul 27, 2021Daily Deal Round Up: July 26, 2021
SoftBank’s Opportunity Fund took part in blockchain payment network Paystand's $50m series C round while Flipkart co-led consumer brand builder G.O.A.T Brand Labs' $36m series A.
Jul 26, 2021Daily Deal Round Up: July 22, 2021
Several corporates backed a $68m series D round for microbiome drug developer Vedanta Biosciences while grooming brand owner Pangaea raised the same amount from investors including Unilever.
Jul 22, 2021Daily Deal Round Up: July 21, 2021
6 Dimensions Capital-backed neuromodulation technology developer Neuspera closed a $65m round while gene therapy developer Coave Therapeutics hiked its latest round to $39m.
Jul 21, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


